Abstract
Background: Being highly contagious through person-to-person transmission, COVID-19 can easily spread within multinational populations of ships and to land communities. The purpose of this study is to report on the prevalence of COVID-19 infections in the Commerce fleet over a two year period and to discuss measures to prevent and overcome the outbreak of COVID-19 on ships. Materials and methods: All possible cases of COVID-19 among crew on six merchant vessels were registered during 2021 by onboard medical facilities. The patients remained isolated for up to 6 days after taking a PCR test. Vulnerable contacts were identified and offered post-exposure measures. The nationality of the crew, the number of contacts vaccinated, and the cost of direct treatment were noted. Results: Across the year of 2021, there were six ships with registered COVID-19 cases (132 crew), and one out of the six ships had COVID-19 cases appearing less frequently than 1 per day, consisting of a total of 12 patients. This ship sails under the flag of the Indonesian state. Of the other five ships, among the crew, 111 caught COVID-19 (85.1% of crew cases were from Indonesia, and 21 (15.9%) of were from subtropical/tropical countries, namely India). Conclusions: All ships have to deal with cases of COVID-19 or outbreaks on board every few years. Any case of COVID-19 could start an outbreak, and thus trigger time-consuming and expensive containment measures, including isolation and mass vaccination of susceptible contacts. Mandatory pre-contract proof of COVID-19 immunity from all seafarers or from subgroups, noting their position or nationality may be worth considering. In order for sailors to be immune to COVID-19, they must be able to get COVID-19 vaccinations and valid documentation when sailing.
Author Contributions
F. responsible to drat and analysis, S.S. responsible to review. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not available due to using secondary data.
Data Availability Statement
Not applicable.
Conflicts of Interest
The authors declare no conflict of interest.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).